TRPM5 and TRPA1 activation can improve insulin secretion and negatively correlate with T2DM development, whereas TRPC6, TRPV4 and TRPM2 antagonism can slow down diabetes progression. The gene discussed is TRPV4; the disease is type 2 diabetes mellitus.